FDA OKs First Pill for Postpartum Depression

(MedPage Today) -- The FDA approved zuranolone (Zurzuvae) as the first oral treatment for postpartum depression, the agency announced late on Friday. Until now, brexanolone (Zulresso) has been the only other treatment with an indication for postpartum...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news